Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine treatment in bipolar disorder with obsessional symptoms
IRCT20190307042963N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of quetiapine in bipolar disorder (BD) and obsessive compulsive disorder (OCD), sponsored by Shiraz University of Medical Sciences. Started May 2019; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT20190307042963N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190307042963N1.